Cite

HARVARD Citation

    Patel, D. et al. (n.d.). 130 Immunogenic potential of chimeric antigen receptor (CAR)-engineered T cells expressing inducible nuclease-deactivated SpCas9 (dCas9). Journal for immunotherapy of cancer. p. A80. [Online]. 
  
Back to record